Physician group touts ivermectin as flu, RSV treatment — but it’s unproven

A group of physicians that promoted ivermectin as a COVID-19 medication, which was disregarded, is now touting the drug as a treatment for influenza and respiratory syncytial virus despite a lack of evidence, The Washington Post reported Feb. 26. 

Advertisement

The physician group formed in 2020 as the Front Line COVID-19 Critical Care Alliance to help “prevent and treat COVID.” In a recent post, the FLCCC said masks make people sicker and social distancing is a myth. The group also says ivermectin can be used to treat COVID-19, flu and RSV as the CDC and other medical experts strongly disagree. 

The FLCCC cites test tube studies for their treatment recommendations, but John Moore, PhD, a microbiology and immunology professor at Weill Cornell Medical College in New York City, pushed back on this connection. 

“If you threw Coca-Cola into cell culture, you would see an antiviral effect,” Dr. Moore told the Post. “But you wouldn’t want to be squirting Coca-Cola up your nose against the flu and RSV.”

Multiple studies have shown ivermectin is not an effective treatment for COVID-19, and the World Health Organization agrees. A CDC spokesperson told the Post the drug is not a proven treatment for flu or RSV.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

How Leading Pharmacies Stay Stocked And Protect Margins

Thursday, July 23
12:00 PM - 1:00 PM CDT

Presenters: Calvin Hunsicker, SureCostChad O’Connor, SureCost

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.